Coronavirus channel feed

Sen­ate pro­pos­es $16B to fund the next wave of Covid-19 vac­cines, ther­a­peu­tics in 2023

3 years ago
FDA+

EMA re­views re­pur­posed ex­per­i­men­tal can­cer drug for Covid-19, even with­out a sub­mis­sion

3 years ago

Covid-19 roundup: Pfiz­er, BioN­Tech forge ahead with en­hanced vac­cine; Brii moves on an­ti­body to counter sub­vari­ants

3 years ago

Fau­ci calls for de­vel­op­ment of pan-coro­n­avirus and in­tranasal vac­cines in fight against Covid vari­ants

3 years ago
Pharma

Pfiz­er and BioN­Tech hit back against Cure­Vac suit over Covid-19 vac­cine patents

3 years ago
Pharma
Law

Pfiz­er con­sid­ers an­tivi­ral op­tions as Paxlovid use sky­rock­ets amid wor­ries of re­sis­tance

3 years ago

Covid-19 roundup: New Omi­cron sub­vari­ant first found in In­dia sparks de­bate on sever­i­ty; Ap­proval for Sh­ionogi's oral treat­ment de­layed

3 years ago

Up­dat­ed: Study shows As­traZeneca's Covid-19 mAb Evusheld may not work against dom­i­nant Omi­cron strain

3 years ago

Val­neva's Covid-19 vac­cine con­tract with Eu­rope col­laps­es to just a frac­tion of the orig­i­nal deal

3 years ago

No­vavax fo­cus­es on vari­ant-spe­cif­ic vac­cines in ex­pand­ed deal with South Ko­re­an man­u­fac­tur­er

3 years ago
Pharma
Manufacturing

Covid-19 roundup: No­vavax set to re­lease its first vac­cine batch in US; Switzer­land to buy over 1200 dos­es of Evusheld

3 years ago

Phar­ma's new 'Ber­lin De­c­la­ra­tion' seeks to re­serve vac­cines, ther­a­peu­tics in pro­duc­tion for low-in­come coun­tries

3 years ago

mR­NA al­ter­na­tive: No­vavax fi­nal­ly scores EUA for pri­ma­ry Covid-19 vac­cine se­ries

3 years ago
FDA+

Covid-19 roundup: FDA re­port­ed­ly set to au­tho­rize No­vavax jab; As­traZeneca says its shot just as ef­fec­tive as mR­NA

3 years ago

With failed NIH Covid-19 study, Hu­mani­gen CEO points to com­peti­tors' flops be­fore FDA nods

3 years ago
R&D

Surge of BA.5: Biden of­fi­cials to stay the course with Covid strat­e­gy, prep for bi­va­lent boost­ers in Oc­to­ber

3 years ago

Covid-19 roundup: EMA rec­om­mends an ad­di­tion­al boost­er dose; Mod­er­na touts shot tar­get­ing Omi­cron sub­vari­ants

3 years ago

FDA says it won't al­low state-li­censed phar­ma­cists to pre­scribe Mer­ck­'s Lagevrio

3 years ago
Pharma

Africa strikes deal with Pfiz­er for Covid-19 an­tivi­ral — re­port

3 years ago
Pharma

Phar­ma­cists 'ready to get to work' af­ter new FDA au­tho­riza­tion al­lows them to pre­scribe Pfiz­er's Covid-19 an­tivi­ral

3 years ago
Pharma

In wake of IP claims tar­get­ing its megablock­buster, BioN­Tech mulls a few next steps of its own

3 years ago
Law

Covid-19 roundup: No­vavax vac­cine au­tho­rized in EU for teens; CEPI backs Co­di­ak's ef­forts on be­ta­coro­n­avirus shot

3 years ago

Covid-19 roundup: Ox­ford Bio­med­ica and As­traZeneca ex­tend vac­cine deal; FDA wants boost­ers for new­er vari­ants

3 years ago
FDA+

As boost­er sea­son awaits, US re-ups sup­ply of Pfiz­er Covid-19 vac­cine with new $3.2B deal

3 years ago
First page Previous page 6789101112 Next page Last page
A service from the Financial Times